Continuation of Research and Development Activities
First written in FY2016-Q2. 27 of 31 entries say "Restated". Latest entry: FY2026-H1.
9 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥23 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
Recorded ¥23 million in R&D expenses and continued to state that there were no material changes in the status of R&D activities. - FY2025RestatedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥61.204 million. In the electronic circuit board business, the Company is conducting R&D to form and stably supply high-density wiring circuits through high-precision line-width control, as well as to achieve greater heat resistance, flexibility and high-frequency performance than before. In the test systems business, it is developing inspection systems aimed at reducing false positives and improving detection capabilities through enhanced AI technology.」
Continued R&D activities and identified high-density, high-heat-resistance and high-frequency electronic circuit board technologies, together with AI-based inspection system development, as key focus areas. - FY2025-H1RestatedAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥38 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
Recorded ¥38 million in R&D expenses and continued to state that there were no material changes in the status of R&D activities. - FY2024AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥85.079 million. In the electronic circuit board business, the Company is conducting R&D to form and stably supply high-density wiring circuits through high-precision line-width control, as well as to achieve greater heat resistance, flexibility and high-frequency performance than before. In the test systems business, it is developing inspection systems aimed at reducing false positives and improving detection capabilities through enhanced AI technology.」
R&D expenses were ¥85.079 million, with specific initiatives identified in high-density, high-heat-resistance and high-frequency electronic circuit boards, as well as AI-based inspection system development. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥35 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
Recorded ¥35 million in R&D expenses and continued to state that there were no material changes in the status of R&D activities. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥13 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
Recorded ¥13 million in R&D expenses and continued to state that there were no material changes in the status of R&D activities. - FY2023RestatedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥66.990 million. In the electronic circuit board business, the Company is conducting R&D on forming electronic circuits on special organic materials. In the test systems business, it is conducting R&D on inspection systems that use AI technology and new inspection systems for 5G-compatible FPCs, among other areas.」
Continued R&D activities and recorded ¥66.990 million in R&D expenses. Continued to identify special organic materials, AI inspection systems and 5G-compatible FPC inspection systems, among other areas, as key focus areas. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥53 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
Recorded ¥53 million in R&D expenses and continued to state that there were no material changes in the status of R&D activities. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥38 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
Recorded ¥38 million in R&D expenses and continued to state that there were no material changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the first quarter were ¥20 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
Recorded ¥20 million in R&D expenses and continued to state that there were no material changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the second quarter were ¥58 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
R&D expenses of ¥58 million were recorded for the cumulative second-quarter period, and the explanation that there were no significant changes in the status of R&D activities was continued. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the first quarter were ¥33 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
R&D expenses of ¥33 million were recorded, and the explanation that there were no significant changes in the status of R&D activities was continued. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the second quarter were ¥50 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
R&D expenses of ¥50 million were recorded, and the explanation that there were no significant changes in the status of R&D activities was continued. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the first quarter were ¥27 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
R&D expenses of ¥27 million were recorded for the first quarter, and the explanation that there were no significant changes in R&D activities was continued. - FY2020AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥93.631 million. In the electronic substrates business, R&D focused on forming electronic circuits on special organic materials. In the test systems business, R&D focused on inspection systems using AI technology and new inspection systems for 5G-compatible FPCs, among other areas.」
R&D expenses were ¥93.631 million, with specific focus areas including special organic materials, AI inspection systems, 5G-compatible FPC inspection systems, and inspection for automotive and mobile FPCs. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the nine-month period of the current consolidated fiscal year were ¥70 million. There were no material changes in the status of our group's R&D activities during the nine-month period of the current consolidated fiscal year.」
R&D expenses of ¥70 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the second quarter were ¥47 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
R&D expenses of ¥47 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the first quarter were ¥22 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
R&D expenses of ¥22 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2019AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥74.187 million. In the electronic substrates business, R&D focused on forming electronic circuits on special organic materials. In the test systems business, R&D focused on inspection systems using AI technology and new inspection systems for 5G-compatible FPCs, among other areas.」
R&D expenses were ¥74.187 million, with specific focus areas including AI inspection systems, 5G-compatible FPC inspection and special organic materials. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the third quarter were ¥56 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
R&D expenses of ¥56 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the second quarter were ¥35 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
R&D expenses of ¥35 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the first quarter were ¥16 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the first quarter.」
R&D expenses of ¥16 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the third quarter were ¥46 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
R&D expenses of ¥46 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the second quarter were ¥32 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
R&D expenses of ¥32 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥18 million. There was no material change in the status of the group’s R&D activities during the first quarter of the current consolidated cumulative period.」
R&D expenses of ¥18 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the third quarter were ¥50 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
R&D expenses of ¥50 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the second quarter were ¥33 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
R&D expenses of ¥33 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2017-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current fiscal year were ¥19 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current fiscal year.」
R&D expenses of ¥19 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2016RestatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥68.469 million. R&D activities included forming electronic circuits on special organic materials for printed wiring boards, improving defect-detection performance for high-definition, high-density substrates and conducting non-contact inspections for substrate inspection machines, and improving inspection accuracy and reducing equipment footprint for inspection systems.」
R&D expenses of ¥68.469 million were recorded, with specific R&D activities described in the areas of electronic substrates, substrate inspection machines and inspection systems. - FY2016-Q3RestatedAnnual report
「Total R&D expenses for the cumulative consolidated period through the third quarter were ¥53 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the third quarter.」
R&D expenses of ¥53 million were recorded, and the explanation that there were no significant changes in R&D activities was continued. - FY2016-Q2First statedAnnual report
「Total R&D expenses for the cumulative consolidated period through the second quarter were ¥36 million. There were no significant changes in the status of the Group's R&D activities during the cumulative consolidated period through the second quarter.」
R&D expenses of ¥36 million were recorded, and it was stated that there were no significant changes in R&D activities.